| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 131 | 147 | 163 | 150 | 155 | 167 | 230 | 213 | 199 | 198 | 231 | 228 | 641 | 237 | 254 | 273 | 284 | 279 | 290 | 317 | 302 | 297 | 352 | 358 | 363 | 323 | 351 | 362 | 388 | 342 | 339 | 378 | 368 | 334 | 356 | 337 | 365 | 393 | 373 | 397 | 403 | 445 | 426 |
| Expenses | 130 | 128 | 137 | 144 | 143 | 157 | 208 | 201 | 176 | 178 | 179 | 210 | 213 | 213 | 224 | 235 | 243 | 240 | 247 | 266 | 256 | 250 | 300 | 291 | 319 | 300 | 331 | 322 | 350 | 342 | 335 | 365 | 432 | 365 | 331 | 307 | 334 | 348 | 334 | 357 | 356 | 391 | 370 |
| EBITDA | 1 | 19 | 26 | 6 | 12 | 10 | 22 | 12 | 22 | 20 | 52 | 19 | 428 | 24 | 30 | 38 | 41 | 40 | 43 | 51 | 47 | 47 | 52 | 67 | 45 | 23 | 20 | 40 | 37 | -0 | 4 | 13 | -63 | -31 | 25 | 30 | 32 | 45 | 39 | 40 | 48 | 55 | 56 |
| Operating Profit % | 0 % | 12 % | 13 % | 2 % | 6 % | 5 % | 8 % | 3 % | 11 % | 8 % | 10 % | 7 % | 8 % | 10 % | 11 % | 13 % | 14 % | 14 % | 13 % | 16 % | 15 % | 15 % | 14 % | 18 % | 12 % | 6 % | 6 % | 10 % | 9 % | -0 % | 1 % | 3 % | -18 % | -10 % | 4 % | 7 % | 8 % | 11 % | 9 % | 9 % | 11 % | 12 % | 13 % |
| Depreciation | 10 | 9 | 9 | 11 | 16 | 13 | 16 | 13 | 10 | 10 | 10 | 12 | 10 | 10 | 10 | 11 | 11 | 12 | 13 | 13 | 13 | 13 | 13 | 12 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 | 15 | 14 | 15 | 16 | 17 | 16 | 17 | 17 | 16 | 15 | 16 |
| Interest | 11 | 11 | 8 | 8 | 10 | 8 | 9 | 8 | 7 | 6 | 7 | 10 | 10 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 9 | 8 | 7 | 6 | 3 | 3 | 3 | 4 | 6 | 7 | 8 | 10 | 11 | 11 | 13 | 13 | 12 | 16 | 14 | 15 | 15 | 14 | 14 |
| Profit Before Tax | -16 | 1 | 8 | -8 | -15 | -11 | -2 | -9 | 6 | 4 | 34 | -3 | 409 | 7 | 12 | 18 | 22 | 19 | 23 | 28 | 24 | 26 | 32 | 50 | 29 | 7 | 4 | 24 | 18 | -21 | -18 | -10 | -89 | -56 | -3 | 2 | 3 | 12 | 8 | 8 | 16 | 26 | 27 |
| Tax | 3 | 1 | 1 | 1 | 0 | 1 | 2 | 2 | -5 | 2 | 4 | 4 | 4 | 2 | -3 | 3 | 0 | 4 | -2 | 4 | 6 | 7 | 8 | 12 | 6 | 5 | -10 | 5 | 8 | -6 | -13 | -0 | 4 | -21 | 4 | -9 | 1 | 3 | 2 | 2 | 6 | 8 | 8 |
| Net Profit | -19 | -0 | 7 | -8 | -15 | -12 | -4 | -11 | 11 | 2 | 31 | -7 | 405 | 5 | 16 | 16 | 21 | 15 | 25 | 24 | 18 | 19 | 24 | 38 | 24 | 3 | 14 | 19 | 10 | -15 | -4 | -10 | -92 | -35 | -7 | 11 | 1 | 9 | 6 | 7 | 10 | 18 | 20 |
| EPS in ₹ | -7.09 | 0.01 | 1.27 | -0.50 | -0.55 | -0.43 | -0.22 | -0.21 | 0.28 | 0.09 | 1.21 | -0.39 | 0.14 | 0.14 | 0.63 | 0.54 | 0.71 | 0.47 | 0.88 | 0.83 | 0.69 | 0.93 | 0.86 | 1.45 | 0.84 | 0.04 | 0.58 | 0.69 | 0.36 | -0.60 | -0.15 | -0.36 | -3.77 | -1.40 | -0.34 | 0.33 | -0.04 | 0.26 | 0.11 | 0.14 | 0.37 | 0.57 | 0.59 |
Sequent Scientific
Sequent Scientific
223.46
-2.93
(-1.29%)
Market Cap
₹5,623.43 Cr
PE Ratio
111.75
Volume
12,11,340.00
Day High - Low
₹226.98 - ₹220.65
52W High-Low
₹257.85 - ₹117.35
There are new updates from the company23 hours ago
View
Key Fundamentals
Market Cap
5,623.43 Cr
EPS
0.88
PB Ratio
7.47
Book Value
32.00
EBITDA
176.50
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals ROE Growth %
-
Debt to Equity
0.71
Actual
Company News
View All News
Sequent Scientific Seeks Shareholder Approval for Name Change to Viyash Scientific Limited1 day ago
Sequent Scientific Limited has issued a postal ballot notice seeking shareholder approval to change its name to Viyash Scientific Limited and alter its business objects clause, following the sanctioning of its composite amalgamation scheme by NCLT on November 18, 2025. The remote e-voting period runs from November 29 to December 28, 2025, with the name change aimed at creating a unified identity reflecting the combined strengths of merged entities and leveraging the Viyash brand equity.
Sequent Scientific Announces Effective Date for Multi-Company Amalgamation Scheme2 days ago
Sequent Scientific's composite scheme of amalgamation involving nine companies including Symed Labs, Vandana Life Sciences, and others became effective from November 27, 2025, following National Company Law Tribunal approval dated November 18, 2025. The scheme consolidates multiple pharmaceutical and life sciences entities under Sequent Scientific, with required regulatory approvals and conditions satisfied.
Sequent Scientific has fixed December 08, 2025 as the record date to determine shareholders of Viyash Life Sciences for allotment of merger consideration shares following NCLT approval of the composite amalgamation scheme. Under the share exchange ratio, Viyash shareholders will receive 56 equity shares of Sequent (Rs. 2 each) for every 100 shares of Viyash (Rs. 10 each) they hold.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,831.60 | #1 4,39,462.19 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 79.43 | |
6,477.00 | 1,71,944.00 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 49.62 | |
3,720.60 | 1,25,922.01 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 53.11 | |
1,531.30 | 1,23,691.38 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 50.63 | |
1,258.80 | 1,05,061.18 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 57.24 | |
2,082.20 | 95,105.43 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 65.07 | |
942.50 | 94,837.55 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 44.36 | |
2,251.00 | 92,911.94 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 38.76 | |
1,226.70 | 71,246.94 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.81 | |
5,685.00 | 67,972.70 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 53.82 |
Growth Rate
Revenue Growth
13.43 %
Net Income Growth
-209.12 %
Cash Flow Change
172.42 %
ROE
-200.96 %
ROCE
-1,430.56 %
EBITDA Margin (Avg.)
115.08 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 908 | 1,528 | 1,905 | 1,343 | 1,388 | 1,463 | 1,393 | 1,451 | 1,529 | 1,540 | 1,602 |
| Fixed Assets | 474 | 587 | 684 | 476 | 498 | 577 | 536 | 564 | 605 | 592 | 586 |
| Current Assets | 310 | 491 | 728 | 538 | 600 | 704 | 714 | 783 | 780 | 811 | 873 |
| Capital Work in Progress | 39 | 24 | 33 | 18 | 23 | 13 | 31 | 12 | 55 | 16 | 16 |
| Investments | 1 | 428 | 428 | 239 | 180 | 172 | 83 | 38 | 0 | 4 | 0 |
| Other Assets | 394 | 491 | 760 | 610 | 687 | 701 | 744 | 837 | 869 | 929 | 1,000 |
| Total Liabilities | 908 | 1,528 | 1,905 | 1,343 | 1,388 | 1,463 | 1,393 | 1,451 | 1,529 | 1,540 | 1,602 |
| Current Liabilities | 406 | 290 | 664 | 431 | 434 | 495 | 460 | 512 | 559 | 627 | 505 |
| Non Current Liabilities | 264 | 290 | 247 | 227 | 207 | 236 | 156 | 199 | 221 | 200 | 327 |
| Total Equity | 238 | 948 | 994 | 685 | 747 | 732 | 776 | 740 | 749 | 713 | 770 |
| Reserve & Surplus | 32 | 885 | 928 | 599 | 657 | 637 | 678 | 633 | 649 | 607 | 654 |
| Share Capital | 31 | 48 | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -2 | 24 | -5 | 28 | 0 | -14 | 4 | -16 | 23 | -2 |
| Investing Activities | -157 | -311 | -116 | 7 | -68 | -72 | 10 | -94 | -65 | -6 | -25 |
| Operating Activities | -24 | -0 | -7 | 45 | 116 | 115 | 115 | 31 | 17 | 31 | 83 |
| Financing Activities | 179 | 309 | 147 | -57 | -20 | -43 | -139 | 67 | 32 | -1 | -61 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 53.86 % | 53.86 % | 53.52 % | 53.02 % | 53.02 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.79 % | 52.78 % | 52.76 % | 52.61 % | 52.61 % | 52.61 % | 52.33 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.03 % | 0.00 % | 6.16 % | 5.70 % | 6.45 % | 6.10 % | 6.05 % | 6.15 % | 5.91 % |
| DIIs | 2.68 % | 2.11 % | 1.49 % | 0.51 % | 0.30 % | 0.29 % | 1.66 % | 2.81 % | 2.92 % | 2.92 % | 3.23 % | 5.02 % | 7.59 % | 8.06 % | 9.99 % | 12.02 % | 12.82 % | 12.98 % | 12.91 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.28 % | 19.04 % | 19.57 % | 26.31 % | 27.64 % | 28.20 % | 27.92 % | 28.61 % | 29.03 % | 28.85 % | 29.25 % | 25.11 % | 24.43 % | 25.01 % | 24.00 % | 23.82 % | 23.43 % | 22.37 % | 22.72 % |
| Others | 24.19 % | 25.00 % | 25.42 % | 20.17 % | 19.04 % | 18.72 % | 17.63 % | 15.80 % | 15.26 % | 15.44 % | 8.70 % | 17.08 % | 9.02 % | 8.45 % | 6.80 % | 5.46 % | 5.09 % | 5.89 % | 6.13 % |
| No of Share Holders | 0 | 62,318 | 86,848 | 1,24,014 | 1,67,812 | 1,91,092 | 1,97,176 | 1,93,954 | 1,96,231 | 1,87,474 | 1,84,521 | 1,72,853 | 1,66,593 | 1,63,693 | 1,54,603 | 1,62,574 | 1,58,152 | 1,47,320 | 1,44,085 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.2 | 0.2 | 0.00 | 0.5 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.28 | 0.26 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Sept 2021 |  Dividend | ₹ 0.50 /share | 08 Sept 2021 | 322.30 | 236.15 |
| 17 Sept 2024 |  Annual General Meeting | NA | 17 Sept 2024 | 165.50 | 178.10 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 211.07 | 202.90 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 160.00 | 156.65 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 153.25 | 177.30 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 175.85 | 175.00 |
| 08 Aug 2025 | Annual General Meeting | NA | 08 Aug 2025 | 181.65 | 175.00 |
| 26 Aug 2025 |  Extraordinary General Meeting | NA | 26 Aug 2025 | 175.15 | 174.65 |
| 30 Aug 2025 | Extraordinary General Meeting | NA | 30 Aug 2025 | 173.85 | 169.45 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 215.10 | 228.75 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 hours ago
23 hours agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association3 days ago
3 days agoIntimation Of Record Date Under Regulation 42 Of SEBI3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementNov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementNov 18, 2025
Nov 18, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2025
Nov 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Q2 FY26Nov 14, 2025
Nov 14, 2025Q2 FY26 ResultsNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Nov 11, 2025Proposal For Change In NameNov 08, 2025
Nov 08, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 03, 2025
Nov 03, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 03, 2025
Nov 03, 2025Announcement Under Regulation 30 (LODR)Oct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 06, 2025
Oct 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 04, 2025
Oct 04, 2025Notice Of Postal BallotOct 03, 2025
Oct 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 01, 2025
Oct 01, 2025Announcement Under Regulation 30- UpdateSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 11, 2025
Sep 11, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On September 05 2025Sep 05, 2025
Sep 05, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingAug 30, 2025
Aug 30, 2025Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingAug 30, 2025
Aug 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 30, 2025
Aug 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2025
Aug 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 08, 2025
Aug 08, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2025
Aug 08, 2025Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2025Aug 08, 2025
Aug 08, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth | 0.32% | 4510 | 0.03% | 0.05% | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0.01% | 15 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.19% | 8 | 0.02% | 0.04% | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 0.01% | -8 | 0.00% | 0.00% | |
 Angel One Nifty Total Market Index Fund Direct - Growth | 0.01% | 7 | 0.00% | 0.00% | |
 Mirae Asset Nifty Total Market Index Fund Direct-Growth | 0.01% | 4 | 0.00% | 0.00% | |
 ITI ELSS Tax Saver Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% | |
| ITI Pharma and Healthcare Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Quant Healthcare Fund Direct - Growth | 8.26% | 0 | 0.99% | 1.74% | |
| Quant Small Cap Fund Direct Plan-Growth | 1.58% | 0 | 0.15% | 0.26% | |
 Samco Multi Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 UTI Healthcare Fund Direct-Growth | 1.66% | 0 | 0.18% | 0.34% |
Technical Indicators
RSI(14)
Neutral 50.52
ATR(14)
Less Volatile 10.86
STOCH(9,6)
Oversold 16.88
STOCH RSI(14)
Oversold 9.42
MACD(12,26)
Bearish -2.34
ADX(14)
Strong Trend 33.28
UO(9)
Bearish 34.50
ROC(12)
Downtrend And Accelerating -6.19
WillR(14)
Oversold -86.28
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
